137 related articles for article (PubMed ID: 27735167)
1. Gitelman-like Syndrome with Kanamycin Toxicity.
Santra G; Paul R; Karak A; Mukhopadhay S
J Assoc Physicians India; 2016 May; 64(5):90-92. PubMed ID: 27735167
[TBL] [Abstract][Full Text] [Related]
2. Gitelman-like syndrome: A rare complication of using aminoglycosides in tuberculosis - A case report.
E R V; Parrikar A; Keny S; Lawande D
Indian J Tuberc; 2020 Jul; 67(3):417-418. PubMed ID: 32825884
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
[No Abstract] [Full Text] [Related]
4. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
Bernard E
Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
[No Abstract] [Full Text] [Related]
5. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
Fegiz G
Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
[No Abstract] [Full Text] [Related]
6. Comparison of the combination therapy of capreomycin. Ethionamide. Cycloserine with that of kanamycin. Ethionamide. Cycloserin in the retreatment of pulmonary tuberculosis.
Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):1-13. PubMed ID: 4990959
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
Singla R; Gupta S; Gupta R; Arora VK
Int J Tuberc Lung Dis; 2001 Jun; 5(6):559-63. PubMed ID: 11409584
[TBL] [Abstract][Full Text] [Related]
8. An unusual complication secondary to kanamycin use in a patient of multidrug-resistant pulmonary tuberculosis.
Mathews S; Dole S; Barthwal M; Sahasrabudhe T
Med J Armed Forces India; 2023 Dec; 79(Suppl 1):S280-S282. PubMed ID: 38144646
[TBL] [Abstract][Full Text] [Related]
9. [Effect and toxicity on the combined use of pyrazinamide, ethionamide and kanamycin in the retreatment of pulmonary tuberculosis (author's transl)].
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(4):199-200. PubMed ID: 555425
[No Abstract] [Full Text] [Related]
10. [Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations].
Kaminskaia GO; Karachunskiĭ MA; Kolosovskaia VP
Ter Arkh; 1969 Nov; 41(11):75-9. PubMed ID: 5384752
[No Abstract] [Full Text] [Related]
11. Treatment of resistant pulmonary tuberculosis in Hong Kong with regimens of second-line drugs.
Horsfall PA
Tubercle; 1972 Sep; 53(3):166-73. PubMed ID: 4116994
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
Prasad R; Verma SK; Sahai S; Kumar S; Jain A
Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
[TBL] [Abstract][Full Text] [Related]
13. [Comparison among single, double and triple drug regimens in retreatment. (the seventh series of the trial, B)].
Kekkaku; 1968 Jun; 43(6):199-207. PubMed ID: 5701828
[No Abstract] [Full Text] [Related]
14. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
Bignall JR; Lind A; Rist N
Bull Int Union Tuberc; 1969 Aug; 42():7-57. PubMed ID: 5004884
[No Abstract] [Full Text] [Related]
15. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
Hokama S
Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098
[No Abstract] [Full Text] [Related]
16. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
Zunić D
Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
[No Abstract] [Full Text] [Related]
17. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
[No Abstract] [Full Text] [Related]
18. [Treatment with secondary antitubercular agents].
Ovreberg K
Tidsskr Nor Laegeforen; 1968 May; 88(9):741-9. PubMed ID: 4298856
[No Abstract] [Full Text] [Related]
19. [Gitelman's syndrome: an important differential diagnosis of hypokalemia].
Kurschat C; Heering P; Grabensee B
Dtsch Med Wochenschr; 2003 May; 128(22):1225-8. PubMed ID: 12772080
[TBL] [Abstract][Full Text] [Related]
20. Cycloserine Induced Suicidal Tendencies and Kanamycin Induced Ototoxicity in Indian MDR-TB Patient: A Case Report.
Jangra MS; Chhabra M
Curr Drug Saf; 2018; 13(3):211-213. PubMed ID: 29866015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
